Pictured: Renier Brentjens, Isabelle Rivière & Michel Sadelain
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, February 20, 2014

A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment.

Pictured: Jedd Wolchok & Alexander Rudensky
Announcement
By Esther Napolitano, BS, Science Writer/Editor  |  Monday, January 6, 2014

Immunologist Alexander Rudensky and medical oncologist and immunologist Jedd Wolchok are investigating innovative ways to use the immune system to fight cancer.

Pictured: T cells
In the News
By Julie Grisham, MS, Science Writer/Editor  |  Monday, December 23, 2013

Memorial Sloan Kettering researchers have played a major role in cancer immunotherapy research, named “Breakthrough of the Year” by Science magazine.

Pictured: Alexander Rudensky
Profile
By Celia Gittelson, BA  |  Monday, December 16, 2013

Alexander Rudensky’s research focuses on the role of a subset of white blood cells called regulatory T cells, which are believed to suppress the immune system’s ability to fight tumors.

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
In the News
By Christina Pernambuco-Holsten, MA  |  Friday, December 6, 2013

Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.

Pictured: Clifford Hudis
Video
By Memorial Sloan Kettering  |  Friday, November 1, 2013

Medical oncologist Clifford Hudis says advances in immunology and molecular biology are leading to remarkable successes in cancer treatment.

Mouse glioblastoma tumor with phagocytic macrophages
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, October 15, 2013

Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.

Pictured: Liang Deng
Profile
By Jim Stallard, MA, Writer/Editor  |  Friday, April 26, 2013

Physician-scientist Liang Deng cares for patients with melanoma and other skin cancers, and also conducts innovative research on poxviruses.

Pictured: Major Trends in Modern Cancer Research Seminar
Video
By Julie Grisham, MS, Science Writer/Editor  |  Friday, March 1, 2013

At the seventh annual seminar for high school students and teachers, investigators discuss how cutting-edge biomedical research may ultimately contribute to better treatments for cancer patients.

Pictured: BCG
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Friday, February 1, 2013

Researchers have shed light on how an important treatment for early-stage bladder cancer enters cancer cells to eradicate them.

Pictured: Prasad Adusumilli
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, January 3, 2013

A team from Memorial Sloan Kettering has found that the makeup of immune cells in a lung tumor and in tissue surrounding a tumor can predict whether the cancer will recur after surgery.

Pictured: Marcel R. M. van den Brink
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Friday, December 21, 2012

Memorial Sloan Kettering researchers have shown for the first time that administering a growth factor called interleukin-7 can help patients regenerate T cells more quickly after stem cell transplantation.

Pictured: Michel Sadelain
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, December 18, 2012

Memorial Sloan Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

Pictured: Ming Li
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, December 14, 2012

Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.

Pictured: Michel Sadelain & Jedd Wolchok
Announcement
By Media Staff  |  Wednesday, December 12, 2012

Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.

Center News

Stay Informed

Get the latest information about cancer care and research every month.